Mar. 23 at 9:58 AM
In the official site of New Enterprise Associates (NEA), $
$BDTX $FOLD $LQDA $CELC listed as some of its investments in life science.
Recently NEA closed the acquisition and privatization of NEUE, in which it has gathered a percentage above 30%.
NEUE closed at
$5.60 but the deal price is
$7.33. The investors of NEUE will be paid the
$7.33 in a couple of months maximum and they will make a safe 30%.
NEA has also sold many of its investments like Epizym, AneuRX, Aptiva, Evalve, Dermira, Cascadian etc.
So, the above companies should know about that option to go private with a premium, if NEA increases its stake to any of them.
https://www.nea.com/portfolio?category=life-sciences
